NEWS 80 FEED & ADDITIVE MAGAZINE March 2023 A new study, conducted in collaboration with Professor Åshild Krogdahl and Associate Professor Trond Kortner at the Faculty of Veterinary Medicine at the Norwegian University of Life Sciences and Aker BioMarine, concluded that krill meal and krill oil fulfill the dietary choline needs for growth in farmed Atlantic salmon. Antarctic krill in both its meal and oil forms is a natural and sustainable source of several important nutrients for fish, including phospholipids, omega-3 fatty acids, astaxanthin and choline. The researchers behind this study set out to evaluate whether choline from krill meal or krill oil as part of the dietary feed could help alleviate intestinal steatosis, called lipid malabsorption syndrome (LMS) in severe cases. “Choline is an important nutrient that is necessary for health and growth in fish. It also influences intestinal health. In our research with the Norwegian University of Life Sciences, we tested whether choline from krill could reduce the buildup of excessive lipids in the intestine, causing LMS, which is detrimental to fish health and growth,” said Dr. Kiranpreet Kaur, Director R&D Fish Health and Nutrition, Aker BioMarine, and a corresponding author of this study. Read more >> New study: Krill diet fulfills choline needs in Atlantic salmon New Zealand-based dairy cooperative Fonterra announced its Chief Operating Officer, Fraser Whineray, intends to resign from Fonterra at the end of this financial year on 31 July. Chief Executive Officer Miles Hurrell said Fraser joined Fonterra in 2020 and has made a significant contribution during his time with the business. “Fraser has set the Co-op ambitious goals for decarbonisation and the management of water, and his enterprise leadership helped shape our new strategy and 2030 targets. He will leave our operations business unit in great shape with a longer-term outlook and a sharp focus on efficiency,” he said. Read more>> Fonterra’s COO Fraser Whineray to leave Co-op Fraser Whineray Royal DSM, a global purpose-led science-based company, confirmed that it is resuming Rovimix® Vitamin A production in Sisseln, Switzerland. In November 2022, the firm announced a temporary halt to Vitamin A production at the site. The challenging cost environment cited in 2022 spans energy, raw materials and process material costs, continues in 2023. Restarting production will allow DSM to serve its loyal customers with animal nutrition premix solutions ahead of the shutdown for lifetime extension work planned for the Vitamin A line this summer. The ongoing geopolitical and economic turbulence highlights the importance of maintaining resilient vitamin supply which plays a critical role in food security. Read more>> DSM resumes animal grade Vitamin A production
RkJQdWJsaXNoZXIy MTUxNjkxNQ==